Guide covers five core components of 21 CFR Part 111 quality systems, common FDA cGMP violations, and tips for ...
Draft guidance, issued by the FDA last week, could remove ambiguity and uncertainty that may have so far limited uptake of ...
IRVINE, CA, UNITED STATES, March 23, 2026 / EINPresswire.com / — Qalitex Laboratories, an ISO 17025-accredited third-party ...
The landscape of workplace safety and personal health screenings in the Greater Boston area involves a variety of technical procedures that can often seem complex to the uninitiated. In a major ...
7d
BETMAT Releases Comprehensive Industry Guide on Endotoxin Compliance for Injectable Pharmaceuticals
To address these critical safety requirements, BETMAT Biotechnology LLC has released a specialized operational guide focused on Reliable Endotoxin Testing For Injectable Pharmaceuticals, a systematic ...
LINYI CITY, SHANDONG PROVINCE, CHINA, March 18, 2026 /EINPresswire.com/ -- The preserved mushroom sector has become one ...
ARLINGTON, MA - March 16, 2026 - PRESSADVANTAGE - Drug testing is a routine requirement across many workplaces and ...
IRVINE, CA, UNITED STATES, March 13, 2026 /EINPresswire.com/ -- ISO 17025-accredited testing laboratory explains the ...
An Informational Consumer Analysis of AgelessRx's Prescription Process, NAD+ Therapies, GLP-1 and Compounded Semaglutide ...
A surprising lab discovery reveals a light-powered way to tweak complex drugs faster, cleaner, and later in development.
The FDA is doubling down on its goal to increase biosimilar drug availability in the U.S. with a fresh draft guidance proposing more changes to streamline development of the cheaper biologic copies.
The agency estimates the change could shave $20 million from the cost of developing a new biosimilar drug. The FDA published draft guidance on its website Monday outlining the changes. The policy is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results